Viatris Inc. vs Walgreens Boots Alliance, Inc.: Examining Key Revenue Metrics

Comparing Revenue Trends of Viatris and Walgreens Boots Alliance

__timestampViatris Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 2014771960000076392000000
Thursday, January 1, 20159429300000103444000000
Friday, January 1, 201611076900000117351000000
Sunday, January 1, 201711907700000118214000000
Monday, January 1, 201811433900000131537000000
Tuesday, January 1, 201911500500000120074000000
Wednesday, January 1, 202011946000000121982000000
Friday, January 1, 202117886300000132509000000
Saturday, January 1, 202216262700000132703000000
Sunday, January 1, 202315426900000139081000000
Monday, January 1, 2024147658000000
Loading chart...

Unlocking the unknown

A Tale of Two Giants: Viatris Inc. and Walgreens Boots Alliance, Inc.

In the ever-evolving landscape of the pharmaceutical and retail sectors, Viatris Inc. and Walgreens Boots Alliance, Inc. stand as titans. Over the past decade, Walgreens Boots Alliance has consistently outperformed Viatris in revenue, boasting figures that are approximately ten times higher. In 2023, Walgreens reported a revenue of $139 billion, marking a 5% increase from the previous year, while Viatris saw a decline to $15 billion, a 5% drop from 2022. This trend highlights Walgreens' robust market presence and strategic growth initiatives. However, Viatris' revenue peaked in 2021, showcasing its potential for resurgence. As we look to the future, the absence of Viatris' 2024 data leaves room for speculation. Will Viatris close the gap, or will Walgreens continue its dominance? Stay tuned as these industry leaders navigate the challenges and opportunities of the global market.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025